NEW YORK (GenomeWeb News) – Anagnostics and Molzym today announced a licensing agreement and partnership to develop hybcell Pathogens DNA, a system for the rapid identification of sepsis-causing pathogens from whole blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.